Buy your ASAP Silver, ASAP AGX-32, Colloidal SIlver here October 2007: ABL SilverSol Technology (ASAP, etc.) neutralizes Avian Flu Virus
January 15, 2004: "ASAP Kills  a billion Viruses"
We have the most recent printing of Bill Henderson's 
"Cancer Free" <=Click here

Join our newsletter for "customer-only" specials.

Home 
Our Products
ASAP Solution
 
ASAP Ultimate Skin&Body Care-GEL

ASAP
PET SHIELD-Gel

ASAP-AGX-32  Out of Stock

The New Silver Solution (book)


All You Can Eat™ Starch and Calorie Blocker

CANCER FREE

Buy CMO+

Buy CMO+ cream

CMO+ Facts

CMO+ Dosage Precautions

 Coral Calcium 1™ by BodyGenix

Cordyceps  Mushroom

 Emer'gen-C™ by Alacer

GRAVIOLA by Regalabs NEW

Immune-AssistCritical Care

ImmuneAssist for dogs
K9 Immunity
K9 Transfer Factor

RedRaspberry Extract
(anti-carcinogenic)

Vitamin D-3 (Essential)

Get the facts about CMO cerasomal-cis-9-cetylmyristoleate natural arthritis relief

Additional Info

Compare Calciums
 Coral Calcium Benefits

"Coral Wars" by Bob Barefoot

Toxic Vitamins?

Have you heard about CODEX?
Our supplements are in jeopardy!!


United We Stand!


About us  Privacy 
Feedback   Guarantee
Legal "stuff"   Services

Press Release Source: Clifton Mining Company

American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Technology(TM)
Tuesday October 9, 7:00 am ET

Clifton Mining Company Inc. (OTC : CFTN)

In separate in vitro tests against two strains of the H5N1 avian bird flu subtype, both instances of the virus were successfully neutralized by the American Biotech Labs' ABL SilverSol Technology products; the most recent findings are consistent with prior test using company products against the H3N2 and H1N1 flu subtypes.

SALT LAKE CITY, Oct. 9 /PRNewswire-FirstCall/ - American Biotech Labs (ABL; www.AmericanBiotechLabs.com), creator of a line of powerful products that utilize patented ABL SilverSol Technology(TM) to combat many of the world's most harmful pathogens, today announced successful preliminary results on tests performed using the company's products against three strains of the avian bird flu virus.
 
ADVERTISEMENT

Preliminary in vitro tests performed by two separate independent laboratories, using the company's ABL SilverSol Technology(TM) at 10 parts per million against two strains of the H5-N1 and H3-N2 subtype of the Avian Bird Flu virus, indicated that the ABL products could neutralize the virus.

"While we understand that these are preliminary studies, we are extremely encouraged by the results of this initial testing," said Keith Moeller, a managing director at American Biotech Labs. "Our intent with these studies is to test the ability of the product to disarm or kill the Avian flu virus in a laboratory setting. It is a necessary and valuable next step in our continued efforts to gain an understanding of what this technology can do."

The preliminary results of the tests using ABL products against the H5N1 avian bird flu virus are consistent with a variety of previous tests conducted using company products against the H3N2 and H1N1 flu subtypes. In all cases, ABL SilverSol Technology(TM) was able to successfully neutralize the virus.

ABL is engaged in continuing testing and study programs with a variety of groups and labs in the United States and other nations examining the potential applications of ABL SilverSol Technology(TM).

About American Biotech Labs

American Biotech Labs (ABL; www.AmericanBiotechLabs.com), founded in 1998, utilizes patented processes and technology to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's nano-catalytic silver hydrosol has consistently demonstrated the ability to destroy a wide range of microbes - bacteria, viruses and molds. ABL products can be found at GNC and other fine health food stores under the Silver Biotics® label.

Clifton Mining Company owns approximately 23% of ABL. Clifton trades on the U.S. OTC: (CFTN).

Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.


Source: Clifton Mining Company

The statements on these pages have not been evaluated
  by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, 
or prevent any disease, but rather are dietary supplements intended solely for nutritional use to help the body.
Copyright © 2004 HartAmerica.com  Last modified: September 01, 2008